Latent Tuberculosis Infection Testing Market
1 Introduction to Research & Analysis Reports
1.1 Latent Tuberculosis Infection (LTBI) Testing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Latent Tuberculosis Infection (LTBI) Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Latent Tuberculosis Infection (LTBI) Testing Overall Market Size
2.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size: 2021 VS 2028
2.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Latent Tuberculosis Infection (LTBI) Testing Players in Global Market
3.2 Top Global Latent Tuberculosis Infection (LTBI) Testing Companies Ranked by Revenue
3.3 Global Latent Tuberculosis Infection (LTBI) Testing Revenue by Companies
3.4 Top 3 and Top 5 Latent Tuberculosis Infection (LTBI) Testing Companies in Global Market, by Revenue in 2021
3.5 Global Companies Latent Tuberculosis Infection (LTBI) Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Latent Tuberculosis Infection (LTBI) Testing Players in Global Market
3.6.1 List of Global Tier 1 Latent Tuberculosis Infection (LTBI) Testing Companies
3.6.2 List of Global Tier 2 and Tier 3 Latent Tuberculosis Infection (LTBI) Testing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Latent Tuberculosis Infection (LTBI) Testing Market Size Markets, 2021 & 2028
4.1.2 Tuberculin Skin Test (TST)
4.1.3 Interferon Gamma Released Assay (IGRA)
4.2 By Type - Global Latent Tuberculosis Infection (LTBI) Testing Revenue & Forecasts
4.2.1 By Type - Global Latent Tuberculosis Infection (LTBI) Testing Revenue, 2017-2022
4.2.2 By Type - Global Latent Tuberculosis Infection (LTBI) Testing Revenue, 2023-2028
4.2.3 By Type - Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Latent Tuberculosis Infection (LTBI) Testing Market Size, 2021 & 2028
5.1.2 Hospitals and Clinics
5.1.3 Diagnostic Laboratories
5.1.4 Others
5.2 By Application - Global Latent Tuberculosis Infection (LTBI) Testing Revenue & Forecasts
5.2.1 By Application - Global Latent Tuberculosis Infection (LTBI) Testing Revenue, 2017-2022
5.2.2 By Application - Global Latent Tuberculosis Infection (LTBI) Testing Revenue, 2023-2028
5.2.3 By Application - Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Latent Tuberculosis Infection (LTBI) Testing Market Size, 2021 & 2028
6.2 By Region - Global Latent Tuberculosis Infection (LTBI) Testing Revenue & Forecasts
6.2.1 By Region - Global Latent Tuberculosis Infection (LTBI) Testing Revenue, 2017-2022
6.2.2 By Region - Global Latent Tuberculosis Infection (LTBI) Testing Revenue, 2023-2028
6.2.3 By Region - Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Latent Tuberculosis Infection (LTBI) Testing Revenue, 2017-2028
6.3.2 US Latent Tuberculosis Infection (LTBI) Testing Market Size, 2017-2028
6.3.3 Canada Latent Tuberculosis Infection (LTBI) Testing Market Size, 2017-2028
6.3.4 Mexico Latent Tuberculosis Infection (LTBI) Testing Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Latent Tuberculosis Infection (LTBI) Testing Revenue, 2017-2028
6.4.2 Germany Latent Tuberculosis Infection (LTBI) Testing Market Size, 2017-2028
6.4.3 France Latent Tuberculosis Infection (LTBI) Testing Market Size, 2017-2028
6.4.4 U.K. Latent Tuberculosis Infection (LTBI) Testing Market Size, 2017-2028
6.4.5 Italy Latent Tuberculosis Infection (LTBI) Testing Market Size, 2017-2028
6.4.6 Russia Latent Tuberculosis Infection (LTBI) Testing Market Size, 2017-2028
6.4.7 Nordic Countries Latent Tuberculosis Infection (LTBI) Testing Market Size, 2017-2028
6.4.8 Benelux Latent Tuberculosis Infection (LTBI) Testing Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Latent Tuberculosis Infection (LTBI) Testing Revenue, 2017-2028
6.5.2 China Latent Tuberculosis Infection (LTBI) Testing Market Size, 2017-2028
6.5.3 Japan Latent Tuberculosis Infection (LTBI) Testing Market Size, 2017-2028
6.5.4 South Korea Latent Tuberculosis Infection (LTBI) Testing Market Size, 2017-2028
6.5.5 Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size, 2017-2028
6.5.6 India Latent Tuberculosis Infection (LTBI) Testing Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Latent Tuberculosis Infection (LTBI) Testing Revenue, 2017-2028
6.6.2 Brazil Latent Tuberculosis Infection (LTBI) Testing Market Size, 2017-2028
6.6.3 Argentina Latent Tuberculosis Infection (LTBI) Testing Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Revenue, 2017-2028
6.7.2 Turkey Latent Tuberculosis Infection (LTBI) Testing Market Size, 2017-2028
6.7.3 Israel Latent Tuberculosis Infection (LTBI) Testing Market Size, 2017-2028
6.7.4 Saudi Arabia Latent Tuberculosis Infection (LTBI) Testing Market Size, 2017-2028
6.7.5 UAE Latent Tuberculosis Infection (LTBI) Testing Market Size, 2017-2028
7 Players Profiles
7.1 Qiagen
7.1.1 Qiagen Corporate Summary
7.1.2 Qiagen Business Overview
7.1.3 Qiagen Latent Tuberculosis Infection (LTBI) Testing Major Product Offerings
7.1.4 Qiagen Latent Tuberculosis Infection (LTBI) Testing Revenue in Global Market (2017-2022)
7.1.5 Qiagen Key News
7.2 Sanofi
7.2.1 Sanofi Corporate Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Latent Tuberculosis Infection (LTBI) Testing Major Product Offerings
7.2.4 Sanofi Latent Tuberculosis Infection (LTBI) Testing Revenue in Global Market (2017-2022)
7.2.5 Sanofi Key News
7.3 Oxford Immunotec
7.3.1 Oxford Immunotec Corporate Summary
7.3.2 Oxford Immunotec Business Overview
7.3.3 Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Major Product Offerings
7.3.4 Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Revenue in Global Market (2017-2022)
7.3.5 Oxford Immunotec Key News
7.4 Thermo Fisher Scientific
7.4.1 Thermo Fisher Scientific Corporate Summary
7.4.2 Thermo Fisher Scientific Business Overview
7.4.3 Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Major Product Offerings
7.4.4 Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Revenue in Global Market (2017-2022)
7.4.5 Thermo Fisher Scientific Key News
7.5 Par Sterile
7.5.1 Par Sterile Corporate Summary
7.5.2 Par Sterile Business Overview
7.5.3 Par Sterile Latent Tuberculosis Infection (LTBI) Testing Major Product Offerings
7.5.4 Par Sterile Latent Tuberculosis Infection (LTBI) Testing Revenue in Global Market (2017-2022)
7.5.5 Par Sterile Key News
7.6 Bio-Rad Laboratories
7.6.1 Bio-Rad Laboratories Corporate Summary
7.6.2 Bio-Rad Laboratories Business Overview
7.6.3 Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Major Product Offerings
7.6.4 Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Revenue in Global Market (2017-2022)
7.6.5 Bio-Rad Laboratories Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Latent Tuberculosis Infection (LTBI) Testing Market Opportunities & Trends in Global Market
Table 2. Latent Tuberculosis Infection (LTBI) Testing Market Drivers in Global Market
Table 3. Latent Tuberculosis Infection (LTBI) Testing Market Restraints in Global Market
Table 4. Key Players of Latent Tuberculosis Infection (LTBI) Testing in Global Market
Table 5. Top Latent Tuberculosis Infection (LTBI) Testing Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Latent Tuberculosis Infection (LTBI) Testing Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Share by Companies, 2017-2022
Table 8. Global Companies Latent Tuberculosis Infection (LTBI) Testing Product Type
Table 9. List of Global Tier 1 Latent Tuberculosis Infection (LTBI) Testing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Latent Tuberculosis Infection (LTBI) Testing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Latent Tuberculosis Infection (LTBI) Testing Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Latent Tuberculosis Infection (LTBI) Testing Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Latent Tuberculosis Infection (LTBI) Testing Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Latent Tuberculosis Infection (LTBI) Testing Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Latent Tuberculosis Infection (LTBI) Testing Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Latent Tuberculosis Infection (LTBI) Testing Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Latent Tuberculosis Infection (LTBI) Testing Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Latent Tuberculosis Infection (LTBI) Testing Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Latent Tuberculosis Infection (LTBI) Testing Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Latent Tuberculosis Infection (LTBI) Testing Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Latent Tuberculosis Infection (LTBI) Testing Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Latent Tuberculosis Infection (LTBI) Testing Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Latent Tuberculosis Infection (LTBI) Testing Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Latent Tuberculosis Infection (LTBI) Testing Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Latent Tuberculosis Infection (LTBI) Testing Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Latent Tuberculosis Infection (LTBI) Testing Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Latent Tuberculosis Infection (LTBI) Testing Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Revenue, (US$, Mn), 2023-2028
Table 30. Qiagen Corporate Summary
Table 31. Qiagen Latent Tuberculosis Infection (LTBI) Testing Product Offerings
Table 32. Qiagen Latent Tuberculosis Infection (LTBI) Testing Revenue (US$, Mn), (2017-2022)
Table 33. Sanofi Corporate Summary
Table 34. Sanofi Latent Tuberculosis Infection (LTBI) Testing Product Offerings
Table 35. Sanofi Latent Tuberculosis Infection (LTBI) Testing Revenue (US$, Mn), (2017-2022)
Table 36. Oxford Immunotec Corporate Summary
Table 37. Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Product Offerings
Table 38. Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Revenue (US$, Mn), (2017-2022)
Table 39. Thermo Fisher Scientific Corporate Summary
Table 40. Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Product Offerings
Table 41. Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Revenue (US$, Mn), (2017-2022)
Table 42. Par Sterile Corporate Summary
Table 43. Par Sterile Latent Tuberculosis Infection (LTBI) Testing Product Offerings
Table 44. Par Sterile Latent Tuberculosis Infection (LTBI) Testing Revenue (US$, Mn), (2017-2022)
Table 45. Bio-Rad Laboratories Corporate Summary
Table 46. Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Product Offerings
Table 47. Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Latent Tuberculosis Infection (LTBI) Testing Segment by Type in 2021
Figure 2. Latent Tuberculosis Infection (LTBI) Testing Segment by Application in 2021
Figure 3. Global Latent Tuberculosis Infection (LTBI) Testing Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Latent Tuberculosis Infection (LTBI) Testing Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Latent Tuberculosis Infection (LTBI) Testing Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Latent Tuberculosis Infection (LTBI) Testing Revenue in 2021
Figure 8. By Type - Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share, 2017-2028
Figure 9. By Application - Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share, 2017-2028
Figure 10. By Region - Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share, 2017-2028
Figure 11. By Country - North America Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share, 2017-2028
Figure 12. US Latent Tuberculosis Infection (LTBI) Testing Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Latent Tuberculosis Infection (LTBI) Testing Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Latent Tuberculosis Infection (LTBI) Testing Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share, 2017-2028
Figure 16. Germany Latent Tuberculosis Infection (LTBI) Testing Revenue, (US$, Mn), 2017-2028
Figure 17. France Latent Tuberculosis Infection (LTBI) Testing Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Latent Tuberculosis Infection (LTBI) Testing Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Latent Tuberculosis Infection (LTBI) Testing Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Latent Tuberculosis Infection (LTBI) Testing Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Latent Tuberculosis Infection (LTBI) Testing Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Latent Tuberculosis Infection (LTBI) Testing Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share, 2017-2028
Figure 24. China Latent Tuberculosis Infection (LTBI) Testing Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Latent Tuberculosis Infection (LTBI) Testing Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Latent Tuberculosis Infection (LTBI) Testing Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Revenue, (US$, Mn), 2017-2028
Figure 28. India Latent Tuberculosis Infection (LTBI) Testing Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share, 2017-2028
Figure 30. Brazil Latent Tuberculosis Infection (LTBI) Testing Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Latent Tuberculosis Infection (LTBI) Testing Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share, 2017-2028
Figure 33. Turkey Latent Tuberculosis Infection (LTBI) Testing Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Latent Tuberculosis Infection (LTBI) Testing Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Latent Tuberculosis Infection (LTBI) Testing Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Latent Tuberculosis Infection (LTBI) Testing Revenue, (US$, Mn), 2017-2028
Figure 37. Qiagen Latent Tuberculosis Infection (LTBI) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Sanofi Latent Tuberculosis Infection (LTBI) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Par Sterile Latent Tuberculosis Infection (LTBI) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)